Zacks Investment Research
14 Jul 2026, 16:40 UTC · 2h ago
PACS or ALHC: Which Is the Better Value Stock Right Now?
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.

Zacks Investment Research
14 Jul 2026, 16:40 UTC · 2h ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.

What the story claims
3 claims · each scored for market impact
PACS Group, Inc. currently holds a Zacks Rank of #2 (Buy), indicating positive earnings estimate revision trends. — A 'Buy' rank suggests improving analyst expectations, which typically supports a positive move in the stock price.
+0.30PACS Group, Inc. exhibits stronger value metrics than Alignment Healthcare, with a forward P/E of 19.40 and a Value grade of B. — Lower valuation multiples relative to a peer suggest a more attractive entry point for value-oriented investors.
+0.20Alignment Healthcare has a Zacks Rank of #3 (Hold) and a significantly higher forward P/E ratio of 104.51. — A 'Hold' rank combined with a very high P/E suggests limited immediate upside or a potentially overvalued stock.
-0.20Which stocks this story touches
Continue reading
6 related stories
Top 2 movers · tap to explore
The company has a 'Buy' Zacks Rank and a superior Value grade (B) compared to its peer.
The company has a 'Hold' rank and less favorable valuation metrics compared to PACS.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
Zacks Investment Research
2h ago